This study examined the epidemiological characteristics of 2143 pediatric patients with COVID-19 in China. The key findings were:
1) Children of all ages were susceptible to COVID-19, with no significant gender difference found.
2) Most pediatric cases (over 90%) were asymptomatic, mild, or moderate in severity.
3) The median time from illness onset to diagnosis was 2 days.
4) There was a rapid initial increase then gradual decrease in cases over time, and most cases were concentrated in Hubei Province and surrounding areas, indicating human-to-human transmission.
This study examined the epidemiological characteristics of 2143 pediatric patients with COVID-19 in China. The key findings were:
1) Children of all ages appeared susceptible to COVID-19, with the median age being 7 years and no significant gender difference.
2) Over 90% of pediatric cases were asymptomatic, mild, or moderate in severity. However, young children and infants were more vulnerable to infection.
3) The number of pediatric cases rapidly increased in early January and peaked around February 1st before declining, indicating person-to-person transmission. Most cases were in Hubei province and surrounding areas.
This study examined the epidemiological characteristics of 2143 pediatric patients with COVID-19 in China. The key findings were:
1) Children of all ages appeared susceptible to COVID-19, with the median age being 7 years and no significant gender difference.
2) Over 90% of pediatric cases were asymptomatic, mild, or moderate in severity. However, young children and infants were more vulnerable to infection.
3) The number of pediatric cases rapidly increased in early January and peaked around February 1st before declining, indicating person-to-person transmission. Most cases were in Hubei province and surrounding areas.
This document summarizes a study on the initial characterization of COVID-19 in children. The key findings are:
1) 13% of children with COVID-19 had asymptomatic infections, and preschool-aged children and infants were more likely to have severe clinical manifestations than older children.
2) While children are less likely than adults to have severe illness from COVID-19, some subpopulations of children are at higher risk.
3) Children may play a major role in community transmission through nasal and fecal shedding of the virus. More data is still needed to fully understand the impact and transmission of COVID-19 in children.
Research on covid 19 effects on youthsWaqar Abbasi
This document summarizes the effects of COVID-19 on the mental health and psyche of youth based on interviews. It finds that youth are struggling with overthinking, feelings of loss, sadness, anxiety about the health of family and friends, and disrupted sleep. They are missing important life events like graduation and weekly family dinners. The lockdown has also disrupted daily routines and caused financial stress for many. Overall, the pandemic is taking a significant toll on the psychological well-being of young people.
Covid 19 in children consensus statementgisa_legal
This document presents an experts' consensus statement on the diagnosis, treatment, and prevention of 2019 novel coronavirus (2019-nCoV) infection in children. It summarizes the current strategies based on previous diagnosis and treatment of pediatric virus infections. The key points are: 1) 2019-nCoV infections in children can range from asymptomatic to mild or severe pneumonia, with most cases being mild; 2) Diagnosis is based on epidemiological history, clinical manifestations, and laboratory tests detecting 2019-nCoV nucleic acid; 3) Treatment involves supportive care, symptom relief, oxygen therapy, and antiviral drugs like interferon-α; 4) Prevention focuses on isolation of suspected cases and treatment of confirmed cases.
1. The document discusses the preparedness and awareness of the Local Government Unit (LGU) of Cagayan de Oro City amidst the COVID-19 pandemic.
2. It finds that the majority of respondents considered the LGU's preparedness and awareness in terms of knowledge, preparedness, information update, and preventive measures to be highly effective.
3. The study recommends extending community quarantines, increasing testing and resources for frontline healthcare workers, continuing economic relief for those impacted, and increasing investment in research institutions.
Survey to Assess the Attitude of Nursing Students Regarding Prevention of COV...YogeshIJTSRD
The present study has been conducted to know the attitude of nursing students regarding preventive techniques to prevent from COVID 19 during COVID 19 pandemic. In order to achieve the objectives non experimental approach with survey research design was adopted. Setting of the study selected was Dr. Achal Singh Yadav institute of nursing and paramedical sciences, Lucknow. The selection of sample was done by using convenient non probability sampling technique. The sample size was 30. The method of data collection was using demographic variables questions and structured attitude rating scale related to attitude regarding prevention of COVID 19. Result shown that nursing students had neutral attitude regarding prevention of COVID 19 and there is no significant association between demographic variables with attitude of nursing students, hence hypothesis 1 rejected. Saniya Susan Issac | Sarita Bhatt | Bince Varghese "Survey to Assess the Attitude of Nursing Students Regarding Prevention of COVID-19 during COVID19 Pandemic" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd41258.pdf Paper URL: https://www.ijtsrd.commedicine/nursing/41258/survey-to-assess-the-attitude-of-nursing-students-regarding-prevention-of-covid19-during-covid19-pandemic/saniya-susan-issac
Clinical chacateristics of novel coronavirua in newborns, infants, and childrengisa_legal
This document summarizes the clinical characteristics of COVID-19 in newborns, infants, and children based on reported cases. It finds that pediatric cases are mainly family cluster cases and clinical manifestations in children are generally milder than adults. While rare, severe infections can occur in children as can transmission from mother to child, though likely not intrauterine. Most infected children recover within 1-2 weeks and it is very uncommon for the infection to progress to lower respiratory tract disease in children.
This study examined the epidemiological characteristics of 2143 pediatric patients with COVID-19 in China. The key findings were:
1) Children of all ages appeared susceptible to COVID-19, with the median age being 7 years and no significant gender difference.
2) Over 90% of pediatric cases were asymptomatic, mild, or moderate in severity. However, young children and infants were more vulnerable to infection.
3) The number of pediatric cases rapidly increased in early January and peaked around February 1st before declining, indicating person-to-person transmission. Most cases were in Hubei province and surrounding areas.
This study examined the epidemiological characteristics of 2143 pediatric patients with COVID-19 in China. The key findings were:
1) Children of all ages appeared susceptible to COVID-19, with the median age being 7 years and no significant gender difference.
2) Over 90% of pediatric cases were asymptomatic, mild, or moderate in severity. However, young children and infants were more vulnerable to infection.
3) The number of pediatric cases rapidly increased in early January and peaked around February 1st before declining, indicating person-to-person transmission. Most cases were in Hubei province and surrounding areas.
This document summarizes a study on the initial characterization of COVID-19 in children. The key findings are:
1) 13% of children with COVID-19 had asymptomatic infections, and preschool-aged children and infants were more likely to have severe clinical manifestations than older children.
2) While children are less likely than adults to have severe illness from COVID-19, some subpopulations of children are at higher risk.
3) Children may play a major role in community transmission through nasal and fecal shedding of the virus. More data is still needed to fully understand the impact and transmission of COVID-19 in children.
Research on covid 19 effects on youthsWaqar Abbasi
This document summarizes the effects of COVID-19 on the mental health and psyche of youth based on interviews. It finds that youth are struggling with overthinking, feelings of loss, sadness, anxiety about the health of family and friends, and disrupted sleep. They are missing important life events like graduation and weekly family dinners. The lockdown has also disrupted daily routines and caused financial stress for many. Overall, the pandemic is taking a significant toll on the psychological well-being of young people.
Covid 19 in children consensus statementgisa_legal
This document presents an experts' consensus statement on the diagnosis, treatment, and prevention of 2019 novel coronavirus (2019-nCoV) infection in children. It summarizes the current strategies based on previous diagnosis and treatment of pediatric virus infections. The key points are: 1) 2019-nCoV infections in children can range from asymptomatic to mild or severe pneumonia, with most cases being mild; 2) Diagnosis is based on epidemiological history, clinical manifestations, and laboratory tests detecting 2019-nCoV nucleic acid; 3) Treatment involves supportive care, symptom relief, oxygen therapy, and antiviral drugs like interferon-α; 4) Prevention focuses on isolation of suspected cases and treatment of confirmed cases.
1. The document discusses the preparedness and awareness of the Local Government Unit (LGU) of Cagayan de Oro City amidst the COVID-19 pandemic.
2. It finds that the majority of respondents considered the LGU's preparedness and awareness in terms of knowledge, preparedness, information update, and preventive measures to be highly effective.
3. The study recommends extending community quarantines, increasing testing and resources for frontline healthcare workers, continuing economic relief for those impacted, and increasing investment in research institutions.
Survey to Assess the Attitude of Nursing Students Regarding Prevention of COV...YogeshIJTSRD
The present study has been conducted to know the attitude of nursing students regarding preventive techniques to prevent from COVID 19 during COVID 19 pandemic. In order to achieve the objectives non experimental approach with survey research design was adopted. Setting of the study selected was Dr. Achal Singh Yadav institute of nursing and paramedical sciences, Lucknow. The selection of sample was done by using convenient non probability sampling technique. The sample size was 30. The method of data collection was using demographic variables questions and structured attitude rating scale related to attitude regarding prevention of COVID 19. Result shown that nursing students had neutral attitude regarding prevention of COVID 19 and there is no significant association between demographic variables with attitude of nursing students, hence hypothesis 1 rejected. Saniya Susan Issac | Sarita Bhatt | Bince Varghese "Survey to Assess the Attitude of Nursing Students Regarding Prevention of COVID-19 during COVID19 Pandemic" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd41258.pdf Paper URL: https://www.ijtsrd.commedicine/nursing/41258/survey-to-assess-the-attitude-of-nursing-students-regarding-prevention-of-covid19-during-covid19-pandemic/saniya-susan-issac
Clinical chacateristics of novel coronavirua in newborns, infants, and childrengisa_legal
This document summarizes the clinical characteristics of COVID-19 in newborns, infants, and children based on reported cases. It finds that pediatric cases are mainly family cluster cases and clinical manifestations in children are generally milder than adults. While rare, severe infections can occur in children as can transmission from mother to child, though likely not intrauterine. Most infected children recover within 1-2 weeks and it is very uncommon for the infection to progress to lower respiratory tract disease in children.
This document discusses COVID-19 vaccination during pregnancy. It notes that pregnant women infected with COVID-19 have higher risks of preterm birth, pregnancy loss, and severe illness. While COVID-19 vaccines were not tested in pregnant women during clinical trials, studies since have shown the vaccines generate protective antibodies in pregnant and lactating women as well as in umbilical cord blood and breast milk. The vaccines have shown mild and temporary side effects similar to non-pregnant individuals. Health organizations now recommend pregnant individuals discuss COVID-19 vaccination with their doctors given the risks of infection and limited safety data on the vaccines during pregnancy.
Safety and Success in a Post-Pandemic Society - Daniela Accurso, MD, MPH - 7...Summit Health
The Covid-19 Pandemic has been a health crises that we have been fighting for the last year and a half. Dr. Accurso’s presentation is focused on reviewing how far we have come as a society and to address the questions, health concerns, and important precautions we need to take as we integrate ourselves back into a healthy community.
The document provides information on COVID-19 vaccines in Kentucky. It outlines who is currently eligible to receive the vaccine (phases 1a, 1b, 1c) and discusses key topics like how vaccines work, what mRNA is, safety of the vaccines, possible side effects, number of doses needed, and frequently asked questions.
This study analyzed clinical data from 1099 patients with confirmed COVID-19 in China. It found that the median age was 47 years and the most common symptoms were fever (88.7% developing during hospitalization) and cough (67.8%). Lymphocytopenia was present in 83.2% of patients. The primary endpoint of ICU admission, mechanical ventilation or death occurred in 6.1% of patients. While most cases had contact with Wuhan residents, only 1.9% reported direct contact with wildlife. The study concludes that COVID-19 spread rapidly in China and caused illness of varying severity, with some patients presenting without fever or abnormal radiology.
Forecasting the peak and fading out of novel coronavirus of 2019Islam Saeed
The document summarizes a statistical model that was developed to forecast the size, peak, and fading out of the 2019 novel coronavirus outbreak using confirmed case and death data. The model predicts that:
1) The outbreak will peak on February 20, 2020 with over 91,000 confirmed cases and 1,655 deaths worldwide.
2) The number of cases and deaths will then decline through the end of March 2020 as the outbreak fades out.
3) The outbreak will likely be completely died out by the first week of April 2020, according to the model.
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
Growing evidence suggests that asymptomatic cases could account for 20-50% of total COVID-19 cases and 10-60% of virus transmission. While the risk of catching the virus from completely asymptomatic individuals is low, many people experience only mild symptoms in the early stages of disease and can still spread the virus. This underscores the need for continued strict social distancing even as testing capabilities expand to better track asymptomatic cases and their role in transmission.
The document discusses surveillance of COVID-19, including definitions, objectives, and types of surveillance. Surveillance is defined as the ongoing collection and analysis of health-related data to improve public health. The objectives of COVID-19 surveillance are to rapidly detect cases and contain outbreaks. Types of surveillance discussed are active surveillance through house-to-house searches, passive surveillance through health facilities, and sentinel surveillance through targeted testing. Limitations include underdetection of mild and asymptomatic cases.
This document outlines the timeline of key events related to the COVID-19 pandemic from December 2019 to January 2020. It describes how Chinese health officials began investigating cases of viral pneumonia in Wuhan in December. By late December, doctors were warned about the new disease but were later reprimanded by police for spreading rumors. In early January, a seafood market was shut down and a new coronavirus was identified. The genetic sequence was shared internationally on January 12th, allowing diagnostic tests to be developed. The first cases outside of China were reported shortly after.
The document provides an overview and guide on the 2019 novel coronavirus. It discusses the origin of the virus in Wuhan, China and how it has spread globally. The key symptoms of the virus are fever, cough and shortness of breath. While there is no vaccine or cure currently, treatment focuses on relieving symptoms and recovery support. The document emphasizes the importance of prevention measures like hygiene and being aware of one's environment to minimize risk of infection.
COVID-19 vaccines in cancer patients Dr. Nabil El-HadiNabil El-Hady
This document provides information about COVID-19 vaccination in cancer patients by answering common questions. It discusses that cancer patients are eligible for COVID-19 vaccines as long as they have no contraindications. While vaccines have not been tested in cancer patients, post-authorization studies are planned. The document recommends vaccination timing and managing expected side effects. It also reviews guidelines on vaccination for different cancer types and treatments.
The document discusses the risks of COVID-19 infection in pregnant women based on a study of nine cases in China. It finds that the clinical characteristics and outcomes for pregnant women with COVID-19 were less severe than those seen in pregnant women with SARS. However, more research is still needed given the small number of cases. It recommends pregnant women and newborns be considered at-risk populations and that prevention and management strategies be strengthened.
This document provides a summary of a continuing medical education event on COVID-19 clinical updates and addressing frequent questions. It discusses CME credit information, the virus and transmission, typical and atypical symptoms, risk factors, testing, treatment, prevention strategies, and considerations for vaccine catch-up efforts. It also reviews a case study of a COVID-19 patient and includes slides on topics like the spectrum of illness, comorbidities of concern, prevention through proper hygiene and distancing, and vaccine development efforts.
Public health surveillance of covid 19NOORISLAMBAG
This document provides information on surveillance of COVID-19, including case definitions, types of contact, types of death, objectives and indicators of surveillance, and challenges. It describes the epidemiology of COVID-19 and defines suspected, probable and confirmed cases. Various types of surveillance are outlined, including routine, syndromic, sentinel, hospital-based, and digital surveillance. Challenges of surveillance in low-resource countries include doing more with less and issues with sustainability, underreporting, limited testing capacity, and lack of timeliness in reporting.
Coronavirus ( COVID19 ) CSD ICT Center Global curriculumHaein Shin
Public Health Concern: Coronavirus COVID-19 information share for ICT Center Global trainees.
ICT Center Global Model is a program by Center for Sustainable Development (CSD) at Earth Institute, Columbia University and Infrastructure for Sustainable Development (i4SD)
Evidance based managment of COVID-19 patientsSaren Azer
This document provides guidance on evidence-based management of the COVID-19 outbreak from Dr. Saren Azer, an immunologist and critical care physician. It summarizes recommendations from WHO on screening, infection control, treatment of mild and severe cases, and specimen collection. It emphasizes the importance of infection control and preparing for a potential humanitarian crisis from this pandemic.
Incorporate the visual brilliance of COVID 19 Template PowerPoint Presentation Slides to deliver a gripping presentation. Using the coronavirus PPT theme, you can display global epicenters of this pandemic on a world map diagram. With the help of this corona PowerPoint slideshow, you can spread awareness by communicating symptoms of the disease. Demonstrate the healthcare system capacity and the number of cases using the line graph given in the COVID 19 PPT template. The concise dashboard diagrams included in this 2019-nCoV disease PowerPoint presentation are appropriate to showcase key statistics of the pandemic. Novel coronavirus pneumonia PPT slideshow helps you to highlight the major pandemics of the modern era like the 1700s smallpox outbreak. Elucidate country-wise stats related to the disease using the dashboard layout in this severe pneumonia with novel pathogens PowerPoint theme. So, download this COVID-19 PPT presentation to outline the affected areas, precautionary measures, and other fundamentals. https://bit.ly/3yA9QwF
1) The document discusses the coronavirus (COVID-19) pandemic, providing details on the history and characteristics of coronaviruses, symptoms of COVID-19, definitions used in classifying cases, and accuracy of global data on the spread and mortality risk of the virus.
2) It notes that while coronaviruses have infected humans for years, the current strain spreading worldwide is a version that replicates well at human body temperature.
3) Key terms discussed include incubation period, close contact, suspect/probable/confirmed cases, and stages of COVID-19 illness and recovery times. Global data shows cases are doubling every 3-27 days in different locations.
This presentation showed the impact and the challenges of facing COVID-19 Pandemic and how the world becomes morbid, while the healthcare workforce tries to flatten the "curve".
This document discusses COVID-19 vaccination during pregnancy. It notes that pregnant women infected with COVID-19 have higher risks of preterm birth, pregnancy loss, and severe illness. While COVID-19 vaccines were not tested in pregnant women during clinical trials, studies since have shown the vaccines generate protective antibodies in pregnant and lactating women as well as in umbilical cord blood and breast milk. The vaccines have shown mild and temporary side effects similar to non-pregnant individuals. Health organizations now recommend pregnant individuals discuss COVID-19 vaccination with their doctors given the risks of infection and limited safety data on the vaccines during pregnancy.
Safety and Success in a Post-Pandemic Society - Daniela Accurso, MD, MPH - 7...Summit Health
The Covid-19 Pandemic has been a health crises that we have been fighting for the last year and a half. Dr. Accurso’s presentation is focused on reviewing how far we have come as a society and to address the questions, health concerns, and important precautions we need to take as we integrate ourselves back into a healthy community.
The document provides information on COVID-19 vaccines in Kentucky. It outlines who is currently eligible to receive the vaccine (phases 1a, 1b, 1c) and discusses key topics like how vaccines work, what mRNA is, safety of the vaccines, possible side effects, number of doses needed, and frequently asked questions.
This study analyzed clinical data from 1099 patients with confirmed COVID-19 in China. It found that the median age was 47 years and the most common symptoms were fever (88.7% developing during hospitalization) and cough (67.8%). Lymphocytopenia was present in 83.2% of patients. The primary endpoint of ICU admission, mechanical ventilation or death occurred in 6.1% of patients. While most cases had contact with Wuhan residents, only 1.9% reported direct contact with wildlife. The study concludes that COVID-19 spread rapidly in China and caused illness of varying severity, with some patients presenting without fever or abnormal radiology.
Forecasting the peak and fading out of novel coronavirus of 2019Islam Saeed
The document summarizes a statistical model that was developed to forecast the size, peak, and fading out of the 2019 novel coronavirus outbreak using confirmed case and death data. The model predicts that:
1) The outbreak will peak on February 20, 2020 with over 91,000 confirmed cases and 1,655 deaths worldwide.
2) The number of cases and deaths will then decline through the end of March 2020 as the outbreak fades out.
3) The outbreak will likely be completely died out by the first week of April 2020, according to the model.
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
Growing evidence suggests that asymptomatic cases could account for 20-50% of total COVID-19 cases and 10-60% of virus transmission. While the risk of catching the virus from completely asymptomatic individuals is low, many people experience only mild symptoms in the early stages of disease and can still spread the virus. This underscores the need for continued strict social distancing even as testing capabilities expand to better track asymptomatic cases and their role in transmission.
The document discusses surveillance of COVID-19, including definitions, objectives, and types of surveillance. Surveillance is defined as the ongoing collection and analysis of health-related data to improve public health. The objectives of COVID-19 surveillance are to rapidly detect cases and contain outbreaks. Types of surveillance discussed are active surveillance through house-to-house searches, passive surveillance through health facilities, and sentinel surveillance through targeted testing. Limitations include underdetection of mild and asymptomatic cases.
This document outlines the timeline of key events related to the COVID-19 pandemic from December 2019 to January 2020. It describes how Chinese health officials began investigating cases of viral pneumonia in Wuhan in December. By late December, doctors were warned about the new disease but were later reprimanded by police for spreading rumors. In early January, a seafood market was shut down and a new coronavirus was identified. The genetic sequence was shared internationally on January 12th, allowing diagnostic tests to be developed. The first cases outside of China were reported shortly after.
The document provides an overview and guide on the 2019 novel coronavirus. It discusses the origin of the virus in Wuhan, China and how it has spread globally. The key symptoms of the virus are fever, cough and shortness of breath. While there is no vaccine or cure currently, treatment focuses on relieving symptoms and recovery support. The document emphasizes the importance of prevention measures like hygiene and being aware of one's environment to minimize risk of infection.
COVID-19 vaccines in cancer patients Dr. Nabil El-HadiNabil El-Hady
This document provides information about COVID-19 vaccination in cancer patients by answering common questions. It discusses that cancer patients are eligible for COVID-19 vaccines as long as they have no contraindications. While vaccines have not been tested in cancer patients, post-authorization studies are planned. The document recommends vaccination timing and managing expected side effects. It also reviews guidelines on vaccination for different cancer types and treatments.
The document discusses the risks of COVID-19 infection in pregnant women based on a study of nine cases in China. It finds that the clinical characteristics and outcomes for pregnant women with COVID-19 were less severe than those seen in pregnant women with SARS. However, more research is still needed given the small number of cases. It recommends pregnant women and newborns be considered at-risk populations and that prevention and management strategies be strengthened.
This document provides a summary of a continuing medical education event on COVID-19 clinical updates and addressing frequent questions. It discusses CME credit information, the virus and transmission, typical and atypical symptoms, risk factors, testing, treatment, prevention strategies, and considerations for vaccine catch-up efforts. It also reviews a case study of a COVID-19 patient and includes slides on topics like the spectrum of illness, comorbidities of concern, prevention through proper hygiene and distancing, and vaccine development efforts.
Public health surveillance of covid 19NOORISLAMBAG
This document provides information on surveillance of COVID-19, including case definitions, types of contact, types of death, objectives and indicators of surveillance, and challenges. It describes the epidemiology of COVID-19 and defines suspected, probable and confirmed cases. Various types of surveillance are outlined, including routine, syndromic, sentinel, hospital-based, and digital surveillance. Challenges of surveillance in low-resource countries include doing more with less and issues with sustainability, underreporting, limited testing capacity, and lack of timeliness in reporting.
Coronavirus ( COVID19 ) CSD ICT Center Global curriculumHaein Shin
Public Health Concern: Coronavirus COVID-19 information share for ICT Center Global trainees.
ICT Center Global Model is a program by Center for Sustainable Development (CSD) at Earth Institute, Columbia University and Infrastructure for Sustainable Development (i4SD)
Evidance based managment of COVID-19 patientsSaren Azer
This document provides guidance on evidence-based management of the COVID-19 outbreak from Dr. Saren Azer, an immunologist and critical care physician. It summarizes recommendations from WHO on screening, infection control, treatment of mild and severe cases, and specimen collection. It emphasizes the importance of infection control and preparing for a potential humanitarian crisis from this pandemic.
Incorporate the visual brilliance of COVID 19 Template PowerPoint Presentation Slides to deliver a gripping presentation. Using the coronavirus PPT theme, you can display global epicenters of this pandemic on a world map diagram. With the help of this corona PowerPoint slideshow, you can spread awareness by communicating symptoms of the disease. Demonstrate the healthcare system capacity and the number of cases using the line graph given in the COVID 19 PPT template. The concise dashboard diagrams included in this 2019-nCoV disease PowerPoint presentation are appropriate to showcase key statistics of the pandemic. Novel coronavirus pneumonia PPT slideshow helps you to highlight the major pandemics of the modern era like the 1700s smallpox outbreak. Elucidate country-wise stats related to the disease using the dashboard layout in this severe pneumonia with novel pathogens PowerPoint theme. So, download this COVID-19 PPT presentation to outline the affected areas, precautionary measures, and other fundamentals. https://bit.ly/3yA9QwF
1) The document discusses the coronavirus (COVID-19) pandemic, providing details on the history and characteristics of coronaviruses, symptoms of COVID-19, definitions used in classifying cases, and accuracy of global data on the spread and mortality risk of the virus.
2) It notes that while coronaviruses have infected humans for years, the current strain spreading worldwide is a version that replicates well at human body temperature.
3) Key terms discussed include incubation period, close contact, suspect/probable/confirmed cases, and stages of COVID-19 illness and recovery times. Global data shows cases are doubling every 3-27 days in different locations.
This presentation showed the impact and the challenges of facing COVID-19 Pandemic and how the world becomes morbid, while the healthcare workforce tries to flatten the "curve".
The document discusses the novel coronavirus SARS-CoV-2 (COVID-19) that has become a worldwide threat. It provides an overview of the virus for emergency clinicians, including its epidemiology, prevention, and treatment. Key points are that the case fatality rate is approximately 4% but sampling error may be large, 29% of confirmed cases in China are healthcare workers suggesting alarming nosocomial spread, and gastrointestinal symptoms like diarrhea are common and associated with worse outcomes. Lessons can be learned from early outbreak centers in preparing local healthcare systems for high patient volumes requiring respiratory support.
The document discusses COVID-19 in children. It notes that fewer cases have been reported in children than adults, with children representing about 14% of total cases. As of May 2021, over 3.9 million children in the US had tested positive. Most cases in children are mild and treatment consists of supportive care. The virus is transmitted through respiratory droplets and contact or surfaces. Family clustering appears to play a role in transmission between children. Symptoms in children tend to be mild and include cough, fever, and pharyngeal erythema.
The editorial discusses the Covid-19 outbreak caused by a novel coronavirus. It summarizes a study describing the first 425 cases in Wuhan, China, noting the median age was 59 and higher mortality in the elderly and those with preexisting conditions. While the current fatality rate is around 2%, it may ultimately be closer to seasonal flu if asymptomatic cases are accounted for. The virus has an estimated reproduction number of 2.2, indicating rapid spread. Countries have implemented travel restrictions and should prepare for broader community spread, potentially using social distancing and isolation measures. Research efforts are underway to develop treatments and a vaccine.
The document provides guidelines for COVID-19 surveillance and response in Punjab, Pakistan. It outlines case definitions, epidemiology of COVID-19, alert thresholds, and surveillance protocols. It describes laboratory diagnosis, contact tracing, and the roles and responsibilities of the Provincial Disease Surveillance and Response Unit. Guidelines are provided for clinical management, laboratory sample collection and transport, and infection prevention and control.
The document discusses coronavirus disease (COVID-19) including its definition, transmission, clinical presentation, course, and diagnostic testing recommendations. It defines healthcare personnel and notes COVID-19 is a new coronavirus strain discovered in 2019 that is zoonotic, mainly spread through respiratory droplets. Symptoms can range from mild to severe and include fever, cough and shortness of breath. Older patients and those with chronic conditions are at higher risk. Diagnostic testing is recommended for suspected cases using molecular tests on respiratory specimens.
This document provides an epidemiological update on the novel coronavirus (COVID-19) as of February 14, 2020. It summarizes the global and regional situation, including 49,070 confirmed cases worldwide with the majority in China, and 22 confirmed cases across the United States and Canada in the Region of the Americas. It assessed the overall regional risk as high and provides guidance and recommendations for national authorities, including strengthening surveillance, laboratory testing, and infection prevention and control measures.
The document discusses the COVID-19 pandemic, including the origins and spread of SARS-CoV-2. It describes key events like the virus being first identified in Wuhan, China in late 2019, the WHO declaring a public health emergency in January 2020, and the virus spreading widely in the United States between late January and February 2020. It also discusses recommendations from the CDC on preventive measures like social distancing and mask-wearing during surges. Finally, it lists common comorbidities and risk factors like older age, obesity, and heart or lung conditions that are associated with more severe COVID-19 outcomes.
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...DrHeena tiwari
This study compared the clinical features of COVID-19 in children and youth across the first three waves in multiple countries. A total of 397 patients aged 18 or younger were included. More patients were asymptomatic in the second and third waves compared to the first wave. Most illnesses were mild in all waves. A few patients presented with unusual manifestations like chilblains or multisystem inflammatory syndrome. The study found differences in symptoms and hospital length of stay across the three waves.
The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[4] The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020.[5] As of 25 March, more than 422,000 cases of COVID-19 have been reported in more than 190 countries and territories, resulting in more than 18,900 deaths and more than 109,000 recoveries.
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, in the Hubei Province of China. It is rapidly spreading, resulting in an epidemic throughout china, followed by an increasing number of cases in other countries throughout the world. In February 2020, the WHO designated the disease COVID 19, which stands for corona viruses 2019. The virus that causes COVID 19 is designated severe acute respiratory syndrome coronavirus 2 SARS COV 2 previously, it was referred to as 2019 nCoV. Anushka Bharti | Dr. Gaurav Kumar Sharma | Dr. Kaushal Kishore Chandul "COVID-19" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-6 , October 2021, URL: https://www.ijtsrd.com/papers/ijtsrd46439.pdf Paper URL : https://www.ijtsrd.com/pharmacy/pharmaceutics/46439/covid19/anushka-bharti
Corona viruses are a group of RNA viruses. In late December 2019, Patients with pneumonia with unknown etiology was get admitted in health care facilities in Wuhan, China, and resulted in a pandemic disease which affected more than 200 countries and responsible for 182,989 deaths world wide. The disease is officially named as Coronavirus Disease 2019 COVID 19, by WHO on February 11, 2020 . COVID 19 is a potential zoonotic disease with low to moderate estimated 2 -5 mortality rate. Currently, there is no definite treatment for COVID 19 although some trials are under investigation. Hence, appropriate use of PPE, regular hand hygiene, Respiratory and cough etiquettes, social distancing are some key elements to prevent the spread of disease. Ms. Pabalpreet Kaur | Ms. Eenu | Ms. Pooja Jaswal | Dr. (Mrs.) Jyoti Sarin "The Outbreak of COVID-19: An Overview" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30859.pdf Paper Url :https://www.ijtsrd.com/medicine/nursing/30859/the-outbreak-of-covid19-an-overview/ms-pabalpreet-kaur
Presentation on COVID-19 in March 2020Tehmas Ahmad
The document discusses coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2. It covers the virus's origin in Wuhan, China in late 2019. It describes SARS-CoV-2 as being similar to the SARS virus and using the ACE2 receptor. The disease has since spread globally. Clinical features include fever, cough and pneumonia symptoms, with over 80% of cases being mild. Imaging findings include bilateral ground-glass opacities. There is no vaccine and treatment is supportive.
Thank you for the detailed summary and critical appraisal of the document. This will help provide important context and evaluation of the information presented.
The document discusses the COVID-19 pandemic. It describes how the virus spreads from person to person, its symptoms, and how it began in Wuhan, China in 2019. It then discusses the first cases in the Philippines in January 2020 and the economic impacts the pandemic has had in the country including high unemployment rates. The document also summarizes information on some of the first COVID-19 vaccines developed including those by Pfizer/BioNTech, Moderna, and in China and India.
This document provides guidance for clinicians on the clinical management of patients with severe acute respiratory infection (SARI) when COVID-19 is suspected. It recommends screening all patients for suspected COVID-19 at the first point of contact. It defines mild, severe and critical COVID-19 illness and recommends immediate implementation of infection prevention and control measures. The document is organized to guide clinicians through patient care from screening to management of complications.
- The document summarizes a study on COVID-19 patients hospitalized in Malaysia from February 1-21, 2022 when the Omicron variant was predominant.
- The study found that 2,279 patients were included with a mean age of 41.8, most were female (58.6%) and had no underlying medical conditions (67.4%).
- The risk of disease progression was significantly lower in patients under 50, female, with no comorbidities, and those who had received two doses of vaccination with or without a booster.
The document discusses the novel coronavirus (COVID-19). It begins with an introduction to coronaviruses in general, then discusses the discovery of COVID-19 in Wuhan, China in late 2019. It describes the symptoms of COVID-19, which can range from mild to severe and include fever, cough, and shortness of breath. It explains there are currently no vaccines or antiviral treatments available. The document concludes there is a need for further research to develop targeted antiviral drugs and a vaccine for COVID-19.
Corona virus was first identified as a cause of the common cold in 1960. Until 2002, the virus was considered a relatively simple, nonfatal virus.Over the last three decades there have been three attacks of three different coronaviruses, SARS-CoV, MERS CoV and the recent one 2019 novel coronavirus (2019-nCoV).
Similar to Covid19 peds case summaries pediatrics peds.2020 0702 (20)
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
29. originally published online March 16, 2020;Pediatrics
Yuanyuan Dong, Xi Mo, Yabin Hu, Xin Qi, Fang Jiang, Zhongyi Jiang and Shilu Tong
Disease in China
Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus
Services
Updated Information &
02.citation
http://pediatrics.aappublications.org/content/early/2020/03/16/peds.2020-07
including high resolution figures, can be found at:
Subspecialty Collections
http://www.aappublications.org/cgi/collection/hiv:aids_sub
HIV/AIDS
http://www.aappublications.org/cgi/collection/infectious_diseases_sub
Infectious Disease
sub
http://www.aappublications.org/cgi/collection/adolescent_health:medicine_
Adolescent Health/Medicine
collection(s):
This article, along with others on similar topics, appears in the following
Permissions & Licensing
http://www.aappublications.org/site/misc/Permissions.xhtml
entirety can be found online at:
Information about reproducing this article in parts (figures, tables) or in its
Reprints
http://www.aappublications.org/site/misc/reprints.xhtml
Information about ordering reprints can be found online:
at Erlanger Health System on March 16, 2020www.aappublications.org/newsDownloaded from